MDMA completes 1st phase-3 clinical trial for any psychedelic-assisted therapy, may be magic bullet for PTSD ...News

California-based researchers have completed the first phase-three clinical trial for any psychedelic-assisted therapy and found that MDMA-assisted therapy is more effective at treating PTSD than current methods. While most typically think of MDMA as an illicit party drug, research into the psychoactive chemical and its potential for improving patient outcomes with different forms of the disorder has been ongoing for years. MDMA remains a Schedule 1 drug in the US, which classifies it as having no discernible medical benefit, despite a 2017 FDA description as a “breakthrough therapy” for Post-Traumatic Stress Disorder. In this recent ph

Hence then, the article about mdma completes 1st phase 3 clinical trial for any psychedelic assisted therapy may be magic bullet for ptsd was published today ( Wednesday 12/05/2021 - 07:00 PM ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MDMA completes 1st phase-3 clinical trial for any psychedelic-assisted therapy, may be magic bullet for PTSD )

Also on site :

• Philadelphia Soccer 2026 otvára akreditácie médií a registráciu fanúšikov na festival fanúšikov FIFA Fan Festival™ vo Philadelphii
• China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients
• 1992 No. 1 Hit Ranked Among ‘Greatest Country Songs of All Time’ Became a Timeless Heartbreak Classic, but Never Won an Award